Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Sarcoma 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 5Colonic Neoplasms 4Adenocarcinoma 4Liver Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Neoplasm Metastasis 2Melanoma 2Esophageal Neoplasms 2Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Resectable Pancreatic Ductal Adenocarcinoma 1Prostatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Obesity 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasms 1Motor Activity 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Hepatitis C, Chronic 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 11Specimen Handling 8X-Rays 7Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Biopsy 6olaparib 4ulixertinib 3trametinib 3palbociclib 3larotrectinib 3ivosidenib 3erdafitinib 3dabrafenib 3Vemurafenib 3tipifarnib 2tazemetostat 2selpercatinib 2ensartinib 2durvalumab 2Nivolumab 2LY3023414 2Gemcitabine 2Doxorubicin 2Docetaxel 2Cisplatin 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1sonidegib 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Metformin × Gastrointestinal × Clear all
NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed
15 enrolled
CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡